DNA and RNA replicative machinery (N/A)

The DNA/RNA and replicative DNA polymerase machinery is a multi-component system responsible for the high-fidelity duplication of the genome and the synthesis of RNA transcripts [1][2]. This machinery includes various DNA polymerases (e.g., alpha, delta, epsilon), RNA polymerases, helicases, and primases that coordinate at the replication fork to ensure genetic continuity [2]. In oncology, this system is a primary therapeutic target because cancer cells exhibit accelerated replication rates to sustain rapid tumor growth [4]. Many chemotherapeutic agents, such as antimetabolites and DNA-damaging drugs, exert their effects by stalling this machinery or inducing lethal errors during synthesis [3][5]. Furthermore, viral replication heavily relies on specialized viral polymerases, making them critical targets for antiviral therapies like nucleoside analogs [5]. Despite its therapeutic utility, targeting this machinery often results in significant toxicity to healthy, rapidly dividing tissues such as the bone marrow and intestinal epithelium [1][4].

Other names

ReplisomeDNA replication complexDNA synthesis machineryRNA/DNA polymerase complexReplicative machinery

Inhibition of DNA/RNA polymerase activity, competitive inhibition of nucleotide incorporation, induction of DNA strand breaks, and chain termination.